This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

L'Ontario propose des mesures législatives pour encadrer les réseaux de fournisseurs privilégiés

Après avoir réalisé deux consultations publiques avec des parties prenantes, le gouvernement de l'Ontario (ministère des Finances) va de l'avant avec ses mesures législatives visant...

Canada Healthcare

SB

Smart & Biggar

Branding Medical Devices: Balancing Brand Protection And Regulation

In our recent bulletins, we discussed branding considerations for prescription[1] and over-the-counter drugs[2] in Canada.

Canada Healthcare

ML

McMillan LLP

Ontario proposes legislation to regulate preferred provider networks

Following two public consultations with stakeholders, the Government of Ontario (Ministry of Finance) is moving forward with legislation to regulate preferred provider networks (PPNs).

Canada Healthcare

SB

Smart & Biggar

PCPA Introducing Revisions To Pathway For Non-complex Drug Negotiations

The pan-Canadian Pharmaceutical Alliance (pCPA) recently announced it is formalizing and introducing revisions to the Targeted Negotiation Process (TNP).

Canada Healthcare

SB

Smart & Biggar

Ozempic, A Diabetes Drug Linked To Gastrointestinal Issues And Vision Loss, Approved To Treat Kidney Issues

Canada Healthcare

SL

Siskinds LLP

Changing The Script: Ontario Proposes To Regulate Preferred Provider Networks Between Insurers And Pharmacies

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Étiquetage des produits alimentaires au Canada : Allégations d'origine canadienne et respect des règles de l'ACIA

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Understanding Health Care Rights While Incarcerated: What You Need To Know

Canada Healthcare

HS

Howie, Sacks & Henry LLP

A Further Lesson On Upholding Professional Boundaries

Canada Healthcare

RS

Rosen Sunshine LLP

Un programme pilote de l'Ontario ainsi qu'une nouvelle voie de négociation de l'APP pour accélérer l'accès à des traitements novateurs contre le cancer

Canada Healthcare

SB

Smart & Biggar

Le CEPMB publie son Rapport annuel sur les dépenses des régimes publics d'assurance médicaments (2022-2023)

Canada Healthcare

SB

Smart & Biggar

L'AMC publie sa stratégie visant l'amélioration de la prescription et de l'utilisation appropriées des médicaments d'ordonnance au Canada

Canada Healthcare

SB

Smart & Biggar

Ontario Moves To Regulate Preferred Pharmacy Networks (PPNs)

Canada Healthcare

F

Fasken

Labelling Canadian: Origin Claims And Compliance Under CFIA Rules

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Food and Drugs Law

L'Ontario propose des mesures législatives pour encadrer les réseaux de fournisseurs privilégiés

Après avoir réalisé deux consultations publiques avec des parties prenantes, le gouvernement de l'Ontario (ministère des Finances) va de l'avant avec ses mesures législatives visant...

Canada Healthcare

SB

Smart & Biggar

Branding Medical Devices: Balancing Brand Protection And Regulation

In our recent bulletins, we discussed branding considerations for prescription[1] and over-the-counter drugs[2] in Canada.

Canada Healthcare

ML

McMillan LLP

Ontario proposes legislation to regulate preferred provider networks

Following two public consultations with stakeholders, the Government of Ontario (Ministry of Finance) is moving forward with legislation to regulate preferred provider networks (PPNs).

Canada Healthcare

SB

Smart & Biggar

PCPA Introducing Revisions To Pathway For Non-complex Drug Negotiations

Canada Healthcare

SB

Smart & Biggar

New Food Labelling Rules Incoming

Canada International

MK

Millar Kreklewetz

Ozempic, A Diabetes Drug Linked To Gastrointestinal Issues And Vision Loss, Approved To Treat Kidney Issues

Canada Healthcare

SL

Siskinds LLP

Changing The Script: Ontario Proposes To Regulate Preferred Provider Networks Between Insurers And Pharmacies

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Image de marque fondée sur l'identité canadienne : qu'est-ce que ça implique vraiment?

SB

Smart & Biggar

Étiquetage des produits alimentaires au Canada : Allégations d'origine canadienne et respect des règles de l'ACIA

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

See more

Life Sciences, Biotechnology & Nanotechnology

L'Ontario propose des mesures législatives pour encadrer les réseaux de fournisseurs privilégiés

Après avoir réalisé deux consultations publiques avec des parties prenantes, le gouvernement de l'Ontario (ministère des Finances) va de l'avant avec ses mesures législatives visant...

Canada Healthcare

SB

Smart & Biggar

Branding Medical Devices: Balancing Brand Protection And Regulation

In our recent bulletins, we discussed branding considerations for prescription[1] and over-the-counter drugs[2] in Canada.

Canada Healthcare

ML

McMillan LLP

Ontario proposes legislation to regulate preferred provider networks

Following two public consultations with stakeholders, the Government of Ontario (Ministry of Finance) is moving forward with legislation to regulate preferred provider networks (PPNs).

Canada Healthcare

SB

Smart & Biggar

PCPA Introducing Revisions To Pathway For Non-complex Drug Negotiations

Canada Healthcare

SB

Smart & Biggar

La Cour d'appel fédérale confirme qu'il n'est pas nécessaire de tenir compte des demandes de brevets déposées avant la présentation abrégée de drogue nouvelle pour un médicament générique, mais inscrites au registre après

SB

Smart & Biggar

Les tendances observées dans les demandes de brevets relatives aux technologies médicales assistées par l'intelligence artificielle

SB

Smart & Biggar

Un programme pilote de l'Ontario ainsi qu'une nouvelle voie de négociation de l'APP pour accélérer l'accès à des traitements novateurs contre le cancer

Canada Healthcare

SB

Smart & Biggar

Le CEPMB publie son Rapport annuel sur les dépenses des régimes publics d'assurance médicaments (2022-2023)

Canada Healthcare

SB

Smart & Biggar

Santé Canada publie son Rapport statistique 2024/2025 pour le Règlement sur les médicaments brevetés (avis de conformité), la protection des données et les certificats de protection supplémentaire

SB

Smart & Biggar

See more

Healthcare

Branding Medical Devices: Balancing Brand Protection And Regulation

In our recent bulletins, we discussed branding considerations for prescription[1] and over-the-counter drugs[2] in Canada.

Canada Healthcare

ML

McMillan LLP

Ozempic, A Diabetes Drug Linked To Gastrointestinal Issues And Vision Loss, Approved To Treat Kidney Issues

Ozempic, a diabetes drug that has been the subject of multiple regulatory investigations due to its potential to expose users to serious health risks (including gastrointestinal issues and vision loss)...

Canada Healthcare

SL

Siskinds LLP

Medical Malpractice: Effective Advocacy (Video)

Bethany Nicholson, Associate at Gluckstein Lawyers, shares her expertise on effective advocacy in medical malpractice cases in this session from Risky Business 2025.

Canada Litigation

GP

Gluckstein Lawyers

CPD ACCREDITED Risky Business 2025 Conference: Medical Malpractice In A New Era (Video)

Canada Litigation

GP

Gluckstein Lawyers

The Silent Crisis: Elder Neglect And The Legal System's Role In Change

Canada Litigation

HS

Howie, Sacks & Henry LLP

Employers In B.C. Prohibited From Requesting Medical Notes For Short-Term Absences

Canada Employment

BC

Blake, Cassels & Graydon LLP

Understanding Health Care Rights While Incarcerated: What You Need To Know

Canada Healthcare

HS

Howie, Sacks & Henry LLP

La Cour d'appel fédérale confirme qu'il n'est pas nécessaire de tenir compte des demandes de brevets déposées avant la présentation abrégée de drogue nouvelle pour un médicament générique, mais inscrites au registre après

SB

Smart & Biggar

Les tendances observées dans les demandes de brevets relatives aux technologies médicales assistées par l'intelligence artificielle

SB

Smart & Biggar

See more

Latest Videos

See more

Bothwell V. London Health Sciences Centre, 2023 ONCA 323; Mental Health Injury Update (Video)

SB

SBA Lawyers LLP

Causation: A Judicial Perspective With Madam Justice Darla Wilson And Richard Halpern (Video)

GP

Gluckstein Lawyers

What's Next For Ontario's Public Health Care? (Video)

F

Fasken

The Legal Steps To Startups: Health & Life Science (Video)

PM

Parlee McLaws

How To Protect Ideas In The Booming Life Sciences Sector (Video)

GW

Gowling WLG

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More